Zimmer Biomet
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Zimmer Biomet sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Zimmer Biomet: 115 sponsored US clinical trials, 12 recruiting.
Zimmer Biomet sponsors 115 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 53 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rheumatoid Arthritis, with 13 trials.
Top-decile sponsor footprint
Zimmer Biomet ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
53 of 82 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (64.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 2 of 3
Persona TM Tibia Clinical Outcomes Study
NCT03589300
NexGen TM Tibia Clinical Outcomes Study
NCT03272373
Evaluating Bactisure Wound Lavage in Orthopedic Wounds
NCT03192124
A Cohort Study for Clinical Evaluation of OmniMax MMF System
NCT03075865
BioWick SureLock Clinical Outcomes Study
NCT03199391
Subchondroplasty® Knee RCT
NCT03112200
A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle
NCT03087396
Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty
NCT04326010
Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis
NCT02905240
Zimmer® MotionLoc® in Distal Tibia Fractures
NCT02717546
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
NCT02601430
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)
NCT02262364
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
NCT02175576
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)
NCT02182843
Zimmer POLAR - Total Knee Arthroplasty (TKA)
NCT01859130
Comprehensive Shoulder System Nano IDE
NCT01936259
Sidus Stem-Free Shoulder IDE Study
NCT01878253
A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System
NCT02036931
An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery
NCT01783483
An MRI Investigation of Soft Tissues in Total Hip Arthroplasty
NCT01750606
A Clinical Registry to Collect Patient Outcome Date for the BIOMET® Stimulator Systems
NCT01750840
SCP® Observational Study of the Knee
NCT03110224
Oxford Signature vs. Conventional Global Study
NCT01763684
Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions
NCT01621893
Dynesys Spinal System Post Market 522 Study
NCT01528072
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
NCT01549366
Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis
NCT01560273
Safety and Efficacy of the Oxford Cementless Partial Knee System
NCT01473134
MaxAn Post Market Surveillance Validation
NCT01343693
Continuum™ Metal Bearing System in Total Hip Arthroplasty
NCT03382652
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
NCT01480453
Discovery Elbow Long-Term Survivorship
NCT01308463
Post Market Surveillance to Evaluate the Effectiveness the Polaris Deformity Spinal System
NCT01220505
CopiOs Posterolateral Fusion Procedure
NCT01123850
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
NCT01049919
Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients
NCT01050894
Signature Personalised Patient Care System With the Vanguard Knee System Study
NCT01092312
Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®
NCT00881959
CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation
NCT00889265
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
NCT00854295
Trilogy AB Acetabular Hip System Post Approval Study
NCT00715026
Regenerex Tibial Tray Multi-Center Data Collection
NCT00859963
Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain
NCT00819286
Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
NCT00758719
Clinical Outcomes of the Trinica(R) Anterior Lumbar Plate: Fixed Screws vs. Variable Screws
NCT00762723
Pediatric Locking Nail for the Treatment of Femoral Fractures in Children
NCT00725894
A Double-Blind Study on Adjunctive Use of PEMF in the Treatment of 5th Metatarsal Non-Union Fractures
NCT00586170
Durom(R) Hip Resurfacing System Multicenter Trial
NCT00746616
CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest
NCT00768924
Avascular Necrosis (AVN) Long-Term Follow-up
NCT00833430
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Therapeutic Areas
Where Zimmer Biomet enrollment is open (later-stage tilt)
12 recruiting of 115 indexed (10% open); 53 completed (46%).
Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Rheumatoid Arthritis (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Zimmer Biomet: open-pipeline peers nationwide
Peers matched on 115 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Zimmer Biomet sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 10% open enrollment (± trial volume)
- University of Mississippi Medical Center · 10% recruiting · 96 trials
- Vertex Pharmaceuticals Incorporated · 10% recruiting · 191 trials
- Alexion Pharmaceuticals · 10% recruiting · 162 trials
- SWOG Cancer Research Network · 10% recruiting · 270 trials
Related
What to do with this Zimmer Biomet page
115 registered trials is a research-attention snapshot, not an endorsement of Zimmer Biomet or any single study.
- 12 of Zimmer Biomet's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Rheumatoid Arthritis is the condition Zimmer Biomet studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Zimmer Biomet pipeline card: 115 registered trials from official public datasets.Report a data error.